Alkem Laboratories Completes Acquisition of Swiss Company Occlutech Holding AG
Alkem Laboratories Limited has announced the successful completion of its acquisition of a significant stake in Occlutech Holding AG, a company incorporated in Switzerland. The transaction marks a strategic expansion for the firm as it integrates the Swiss entity into its corporate structure.The acquisition was executed through Alkem Medtech Private Limited, which is a wholly owned subsidiary of Alkem Laboratories in India. Under the terms of the Share Purchase Agreement, Alkem Medtech acquired at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG.
Following the completion of this transaction, Occlutech Holding AG will now function as a step-down subsidiary of Alkem Laboratories Limited. This move follows a series of updates regarding the acquisition process initiated earlier in the year.
The details of the ownership structure are outlined below:
| Entity | Ownership Status | Details |
|---|---|---|
| Alkem Medtech Private Limited | Wholly owned subsidiary | Subsidiary of Alkem Laboratories |
| Occlutech Holding AG | Step-down subsidiary | Acquired by Alkem Medtech |
| Acquisition Stake | 51% to 55% | Equity share capital of Occlutech Holding AG |
ALKEM Stock Price Movement
Alkem Laboratories Limited shares tumbled 2.70% today to settle at ₹5,563. The stock saw a total traded volume of 70,604 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.